Literature DB >> 320110

Correlation between hepatic morphology and immunoglobulins and antibodies to Escherichia coli in cirrhosis.

H Prytz, M Bjorneboe, P Christoffersen, H Poulsen, F Orskov.   

Abstract

Increased antibody production and hypergammaglobulinaemia in cirrhosis are probably to a large extent due to decreased hepatic extraction of antigens. The deceased extraction is presumably related to changed microcirculation caused by damaged anatomical structure of the liver. It is therefore to be expected that immunoglobulin and antibody levels in serum in cirrhotic patients are related to the degree of certain morphological changes of the liver. This hypothesis has been tested. In 50 patients with cirrhosis, 28 alcoholics and 22 non-alcoholics, the degree of architectural destruction, the degree of fibrosis, the degree of fatty infiltration, and the degree of "activity" were compared with immunoglobulins G, A, and M and E. coli O antibody levels. The comparison was carried out within each of the aetiological groups. Identical relationships were found in both groups. Patients with completely destroyed lobular architecture had higher levels of E. coli O antibodies than patients with partly destroyed architecture. Patients with severe fibrosis had higher IgA and E. coli O antibody levels than patients with moderate or slight fibrosis. Patients with moderate and severe steatosis and patients with no or slight steatosis had the same immunoglobulin and E. coli O antibody levels. Patients with active cirrhosis had higher IgG levels than patients with inactive cirrhosis. When architectural destruction and fibrosis were combined significantly higher IgG, IgA, IgM, and E. coli antibodies were found in the group with the most severe changes. These findings support the hypothesis that immunoglobulin and antibody levels are related to the degree of morphological changes in the liver--namely, destruction of lobular architecture, fibrosis, and "activity".

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 320110      PMCID: PMC1411251          DOI: 10.1136/gut.18.1.28

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  The estimation of hepatic blood flow and intrahepatic shunted blood flow by colloidal heat-denatured human serum albumin labeled with I-131.

Authors:  S SHALDON; L CHIANDUSSI; L GUEVARA; J CAESAR; S SHERLOCK
Journal:  J Clin Invest       Date:  1961-07       Impact factor: 14.808

2.  Observations on the influence of medical therapy on portal hypertension in hepatic cirrhosis.

Authors:  C M LEEVY; M ZINKE; J BABER; W Y CHEY
Journal:  Ann Intern Med       Date:  1958-10       Impact factor: 25.391

3.  [Measurement of the blood circulation of the liver and of the phagocytic activity of the reticuloendothelial system in the normal subject and the cirrhotic patient].

Authors:  B N HALPERN; G BIOZZI; G PEQUIGNOT; B DELALOYE; C STIFFEL; D MOUTON
Journal:  Pathol Biol       Date:  1959-08

4.  Significance of alterations in extraction and distribution of colloidal chromic phosphate in patients with liver disease.

Authors:  J G RANKIN; M R PLAYOUST; R W BEAL
Journal:  J Lab Clin Med       Date:  1961-12

5.  The influence of portosystemic shunt operation on immunoglobulins and Escherichia coli antibodies in patients with cirrhosis of the liver.

Authors:  H Prytz; M Bjorneboe; T S Johansen; F Orskov
Journal:  Acta Med Scand       Date:  1974 Jul-Aug

6.  Comparison of immunogenic RNA extracted from peritoneal exudate cells and Kupffer cells of the rat.

Authors:  S J Archer; C J Wust
Journal:  Ann N Y Acad Sci       Date:  1973-05-31       Impact factor: 5.691

7.  Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

Authors:  H C Thomas; R N McSween; R G White
Journal:  Lancet       Date:  1973-06-09       Impact factor: 79.321

8.  Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver.

Authors:  M Bjorneboe; H Prytz; F Orskov
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

9.  Bacterial and dietary antibodies in liver disease.

Authors:  D R Triger; M H Alp; R Wright
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

10.  Normal and pathologic microcirculation of the living mammalian liver.

Authors:  A M Rappaport; R G Black; C C Lucas; J H Ridout; C H Best
Journal:  Rev Int Hepatol       Date:  1966
View more
  7 in total

1.  Hepatitis Bs antibody in alcoholic cirrhosis.

Authors:  P R Mills; T H Pennington; P Kay; R N MacSween; G Watkinson
Journal:  J Clin Pathol       Date:  1979-08       Impact factor: 3.411

2.  In vitro synthesis of IgG by peripheral blood lymphocytes in chronic liver disease.

Authors:  M G Mutchnick; H M Lederman; A Missirian; A G Johnson
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

3.  Development of Hodgkin's disease in the course of liver cirrhosis and impaired monocyte function.

Authors:  M Dan; A Hassner; M Jedwab; S Shibolet
Journal:  Postgrad Med J       Date:  1984-07       Impact factor: 2.401

4.  Autoantibodies, histocompatibility antigens and testosterone in males with alcoholic liver cirrhosis.

Authors:  C Gluud; U Tage-Jensen; M Bahnsen; O Dietrichson; A Svejgaard
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

5.  Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.

Authors:  Jordan J Feld; Nadeem Hussain; Elizabeth C Wright; David E Kleiner; Jay H Hoofnagle; Sushil Ahlawat; Victoria Anderson; Dianne Hilligoss; John I Gallin; T Jake Liang; Harry L Malech; Steven M Holland; Theo Heller
Journal:  Gastroenterology       Date:  2008-03-04       Impact factor: 22.682

6.  Malignant lymphoproliferative disorders in chronic liver disease. Report of four cases and review of the literature.

Authors:  J Naparstek; M Eliakim
Journal:  Am J Dig Dis       Date:  1978-10

7.  Red Blood Cell Distribution Width-to-Platelet Ratio and Other Laboratory Indices Associated with Severity of Histological Hepatic Fibrosis in Patients with Autoimmune Hepatitis: A Retrospective Study at a Single Center.

Authors:  Xu Li; Hongqin Xu; Pujun Gao
Journal:  Med Sci Monit       Date:  2020-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.